#ROR1 - Twitter Hashtag

9 months ago

💡 At #iwNHL25, Philippe Armand will spotlight zilovertamab combinations and their potential impact #NHL #iwNHL #ROR1 #Lymphoma #Lymsm

VJHemOnc's tweet photo. 💡 At #iwNHL25, Philippe Armand will spotlight zilovertamab combinations and their potential impact #NHL

#iwNHL #ROR1 #Lymphoma #Lymsm https://t.co/4EuYO4p9m1

0

5

0

652

Minhua Chu

@chuminhua432

over 1 year ago

🇨🇳 #BR111, an #ADC targeting dual epitopes of #ROR1 developed by #Bioray, has received IND approval in China. #AACR2024, Bioray disclosed that BR111 is developed based on its proprietary CysX platform, with the toxin being a microtubule inhibitor and a DAR of 4.

chuminhua432's tweet photo. 🇨🇳 #BR111, an #ADC targeting dual epitopes of #ROR1 developed by #Bioray, has received IND approval in China. #AACR2024, Bioray disclosed that BR111 is developed based on its proprietary CysX platform, with the toxin being a microtubule inhibitor and a DAR of 4. https://t.co/d1QyN2h0FT

0

5

1

3

733

Minhua Chu

@chuminhua432

over 1 year ago

2/ SYS6005, a recombinant anti-#ROR1 #ADC independently developed by Megalith. Radiance acquire exclusive rights in US, EU, UK, Switzerland, Norway, Iceland, Liechtenstein, Albania, Montenegro, North Macedonia, Serbia, Australia, and Canada

1

2

1

0

497

Minhua Chu

@chuminhua432

over 1 year ago

1/ 🇨🇳 #CSPC registered its ADC candidate #SYS6005 China #NMPA Platform. A Phase I clinical trial (CTR20250511) has been initiated for patients with multiple advanced malignancies, marking it as the 8th ADC from CSPC to enter clinical trials. #ROR1

1

4

2

1

759

OncoDaily

@oncodaily

about 2 years ago

Armoured CAR T-cells engineered to withstand the tumour immunosuppressive micro-environment of solid tumours - @BaleeiroRenato (@VacVBtx) https://t.co/NBNH8HtAWT #oncodaily #oncology #cancer #immunotherapy #solidtumours #CARTcells #ROR1 #TGFβ #cancerresearch #tumourmicroenvironment #groundbreaking #clinicalapplication #immunosuppression #newsletter

0

23

0

143

risk of rain enjoyer @the_doodle_bomb

over 2 years ago

AITA for sending my brother to the moon and stranding him there for eternity? #riskofrain2 #riskofrainreturns #ror1 #ror2 #providence

the_doodle_bomb's tweet photo. AITA for sending my brother to the moon and stranding him there for eternity? #riskofrain2 #riskofrainreturns #ror1 #ror2 #providence https://t.co/3qcO2cte8r

1

44

9

2

871

risk of rain enjoyer @the_doodle_bomb

over 2 years ago

Providence breakdancing... #riskofrain #riskofrain2 #ror2 #ror1 #rorr #riskofrainreturns #animation

1

8

2

1

1K

Carmelo Ferrai @CarmeloFerrai

about 3 years ago

#YAP/#BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in #pancreaticcancer #ROR1 marks aggressive partial #EMT cell cluster and enhances #PDAC proliferation via c-Myc/E2F/AURKB signaling ⁦@embojournal⁩ Masaya Yamazaki lab https://t.co/SiqKVquAjh

0

2

1

0

571

The EMBO Journal @embojournal

about 3 years ago

#YAP/#BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in #pancreaticcancer Masaya Yamazaki et al show that #ROR1 marks an aggressive partial #EMT cell cluster and enhances #PDAC proliferation via c-Myc/E2F/AURKB signaling https://t.co/bKaRrr6ySj

embojournal's tweet photo. #YAP/#BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in #pancreaticcancer
Masaya Yamazaki et al show that #ROR1 marks an aggressive partial #EMT cell cluster and enhances #PDAC proliferation via c-Myc/E2F/AURKB signaling
https://t.co/bKaRrr6ySj https://t.co/lSRMmXaJ6r

0

8

4

3

8K

1stOncology @1stOncology

about 3 years ago

#OncternalTherapeutics Participating in Oppenheimer & Co.’s Virtual Fireside Chat: Discussion of #ROR1 #CART #CellTherapy in #HematologicalMalignancies and #SolidTumors $ONCT https://t.co/e8hA0fepBN

1

2

0

321

Prof Caroline Ford @DrCFord

over 3 years ago

…with funding from @tourdecure_aus @TCRNetwork @CancerSPHERE @UNSW bioinformatician Dr Miya John performed some elegant analysis of expression across healthy and tumour tissue types confirming #ROR1 as a promising oncology drug target in #OvarianCancer

DrCFord's tweet photo. …with funding from @tourdecure_aus @TCRNetwork @CancerSPHERE @UNSW bioinformatician Dr Miya John performed some elegant analysis of expression across healthy and tumour tissue types confirming #ROR1 as a promising oncology drug target in #OvarianCancer https://t.co/IpzjqeyzR5

0

5

1

0

Prof Caroline Ford @DrCFord

over 3 years ago

New publication alert! We explored transcript variants of the #ROR1 & #ROR2 receptors. These are current hot targets in oncology & #ClinicalTrials but there has been confusion about protein/mRNA expression across healthy & tumour tissues. https://t.co/9cvFfHZbQ0 @MDPIOpenAccess

DrCFord's tweet photo. New publication alert! We explored transcript variants of the #ROR1 & #ROR2 receptors. These are current hot targets in oncology & #ClinicalTrials but there has been confusion about protein/mRNA expression across healthy & tumour tissues. https://t.co/9cvFfHZbQ0 @MDPIOpenAccess https://t.co/rtpsxUebrn

1

9

0

Raul Cordoba, MD, PhD #ESCardioOnc26 @DrRaulCordoba

over 3 years ago

#Hematology #ROR1: an orphan becomes apparent | ⁦@BloodJournal⁩ | American Society of Hematology ⁦@ASH_hematology⁩ #CLL #CLLsm #leusm #lymsm https://t.co/qmc212aPzw

0

3

0

Eider Moreno, M.D. @MorenoEider

over 3 years ago · Houston

Thank to my team for the help completing this work under the mentorship of @Dr_JECastro at @MayoClinic / @JoseForeroMD @JuanEGarciaMD #SOHO2022 #CART #CARNK #ROR1

MorenoEider's tweet photo. Thank to my team for the help completing this work under the mentorship of @Dr_JECastro at @MayoClinic / @JoseForeroMD @JuanEGarciaMD #SOHO2022 #CART #CARNK #ROR1 https://t.co/bmjAhJRS84

2

21

0

Duque is a Dingo @DuqueDingoDingo

over 3 years ago

Toughness & Fluffy, StarStorm ROR1 👀 #RiskOfRain #ROR1 #Starstorm #FanArt #Modded

0

3

1

0

SoGiAm @H0U3

almost 4 years ago

$ONCT Quite possibly could be a #takeover in next 12 mos even before we know how well it's working by $ABBV company testing it with their 2 #top #cancer drugs Ibrutinib and Venetoclax. #Ror1 is hot still no reason this should be trading sub #cash value... 2/2

0

1

0

Bertrand Delsuc @BertrandBio

about 4 years ago

Merck $MRK to Hold Investor Event to Highlight Oncology Portfolio and Pipeline #TIGIT #ILT4 #ILT2 #IL2 #ROR1 #CellRx (!!!) #HIF2a #KRASG12C https://t.co/kKRFg4ja8a

BertrandBio's tweet photo. Merck $MRK to Hold Investor Event to Highlight Oncology Portfolio and Pipeline #TIGIT #ILT4 #ILT2 #IL2 #ROR1 #CellRx (!!!) #HIF2a #KRASG12C https://t.co/kKRFg4ja8a https://t.co/BdwUmnyAoe

2

9

3

2

0

Bertrand Delsuc @BertrandBio

about 4 years ago

#NovalGen 🇬🇧 #ROR1 First-in-human phase I study of a ROR1-targeting bispecific T-cell engager (NVG-111) shows evidence of efficacy in patients with relapsed/refractory CLL and MCL. https://t.co/uXvdsUguHz

2

0

2

0

Prof Deborah Marsh @djmarsh24

about 4 years ago

Great to be part of this work led by @DrCFord and @LiuDongli - The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells https://t.co/cMZe9jWkZj #ROR1 #Wnt #zilovertamab #olaparib #ovariancancer #endometrialcancer

2

19

3

0

Mike Thompson, MD, PhD, FASCO

@mtmdphd

about 4 years ago

High expression of ROR1 & ROR1-signaling assoc w/ venetoclax resistance in chronic lymphocytic leukemia [Apr 13, 2022] Ghia et al.@LeukemiaJnl https://t.co/CZf8cHMA0Z #CLLsm #leusm #ROR1 Wnt5a-induced ROR1-signaling can enhance resistance to venetoclax therapy HT @DrRaulCordoba

mtmdphd's tweet photo. High expression of ROR1 & ROR1-signaling assoc w/ venetoclax resistance in chronic lymphocytic leukemia [Apr 13, 2022] Ghia et al.@LeukemiaJnl https://t.co/CZf8cHMA0Z #CLLsm #leusm #ROR1 Wnt5a-induced ROR1-signaling can enhance resistance to venetoclax therapy HT @DrRaulCordoba https://t.co/OP6NUDJta2

0

4

1

0

Top Tweets for #ROR1

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users